Pfizer Income Up 10%

Revenues hit $16.5 billion in Q1

U.S. drugmaker Pfizer said May 3 that despite a 13% fall in sales of its best-selling anti-cholesterol drug Lipitor, first quarter earnings jumped 10%.

Net earnings at the world's biggest pharmaceuticals company grew to $2.22 billion for the January-March period, from $2.01 billion in the same period in 2010.

Revenues were $16.50 billion, down from $16.58 billion, the company said, with Lipitor contributing sales of $2.39 billion, down from $2.76 billion.

International revenues grew 2% despite a 25% drop in foreign Lipitor sales, while revenues inside the United States were down 3%.

The figures do not include gains from the $2.4 billion sale of capsule-maker unit Capsugel to private-equity firm KKR, announced in early April.

Copyright Agence France-Presse, 2011

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.